Cheong Hae Il, Lee Byong Sop, Kang Hee-Gyung, Hahn Hyewon, Suh Kyung-Suk, Ha Il Soo, Choi Yong
Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.
Pediatr Nephrol. 2004 Apr;19(4):454-8. doi: 10.1007/s00467-003-1371-2. Epub 2004 Feb 24.
Complement factor H (FH) deficiency is one of the causes of atypical hemolytic uremic syndrome (HUS). Most patients with FH deficiency associated HUS progress to end-stage renal disease despite plasma therapy. Moreover, the disease invariably recurs in the graft kidney and causes graft failure. We confirmed FH deficiency in a 30-month-old boy with recurrent HUS of 2 years duration, and attempted an auxiliary partial orthotopic liver transplantation (APOLT) to overcome the sustained intractable dependency on plasma therapy. APOLT restored the plasma FH level, without HUS recurrence, for 7 months. However, thereafter he suffered from serious infectious complications associated with immunosuppression and finally died 11 months after APOLT. In conclusion, although APOLT showed clinical and laboratory improvement for some period in this patient, the final fatal outcome suggests that liver transplantation should be cautiously applied to patients with HUS associated with FH deficiency.
补体因子H(FH)缺乏是不典型溶血性尿毒症综合征(HUS)的病因之一。大多数FH缺乏相关的HUS患者尽管接受了血浆治疗,但仍会进展为终末期肾病。此外,该病在移植肾中总是复发并导致移植失败。我们在一名患有持续2年复发性HUS的30个月大男孩中证实了FH缺乏,并尝试进行辅助性部分原位肝移植(APOLT)以克服对血浆治疗的持续难治性依赖。APOLT使血浆FH水平恢复正常,HUS未复发,持续了7个月。然而,此后他出现了与免疫抑制相关的严重感染并发症,最终在APOLT后11个月死亡。总之,尽管APOLT在该患者的一段时间内显示出临床和实验室方面的改善,但最终的致命结局表明,肝移植应谨慎应用于FH缺乏相关的HUS患者。